065170 — BL PharmTech Income Statement
0.000.00%
Last trade - 00:00
- KR₩43bn
- KR₩37bn
- KR₩25bn
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 58,869 | 65,691 | 84,440 | 22,523 | 24,525 |
Cost of Revenue | |||||
Gross Profit | 22,421 | 20,360 | 21,073 | 12,722 | 13,561 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 82,842 | 81,448 | 104,069 | 32,090 | 33,273 |
Operating Profit | -23,972 | -15,758 | -19,630 | -9,567 | -8,748 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16,597 | -14,357 | -20,570 | -14,073 | -13,856 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17,453 | -16,587 | -20,107 | -14,437 | -13,810 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -11,820 | -17,947 | -20,211 | -13,903 | -149 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -11,820 | -17,947 | -20,211 | -13,903 | -149 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 31.1 | -124 | -133 | -128 | -145 |
Dividends per Share |